WallStreetZenWallStreetZen

NYSE: ELAN
Elanco Animal Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ELAN

Based on 5 analysts offering 12 month price targets for Elanco Animal Health Inc

Min Forecast
$18.00-18.37%
Avg Forecast
$21.60-2.04%
Max Forecast
$25.00+13.38%

Should I buy or sell ELAN stock?

Based on 5 analysts offering ratings for Elanco Animal Health Inc.

Strong Buy
Strong Buy
3 analysts 60%
Buy
1 analysts 20%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their ELAN stock forecasts and price targets.

ELAN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-10-20
lockedlocked$00.00+00.00%2025-10-07
lockedlocked$00.00+00.00%2025-09-24
lockedlocked$00.00+00.00%2025-08-11
lockedlocked$00.00+00.00%2025-07-17

1 of 1

Forecast return on equity

Is ELAN forecast to generate an efficient return?

Company
9.75%
Industry
29.5%
Market
-59.4%
ELAN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ELAN forecast to generate an efficient return on assets?

Company
4.81%
Industry
14.19%
ELAN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ELAN earnings per share forecast

What is ELAN's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$0.89+1.28%
Avg 2 year Forecast
$1.00+13.35%
Avg 3 year Forecast
$1.13+27.95%
ELAN's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ELAN revenue forecast

What is ELAN's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$4.6B+2.6%
Avg 2 year Forecast
$4.8B+7.76%
Avg 3 year Forecast
$5.0B+12.18%
ELAN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ELAN earnings growth forecast

How is ELAN forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
8.39%
Industry
23.19%
Market
16.09%
ELAN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ELAN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ELAN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ELAN revenue growth forecast

How is ELAN forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
3.95%
Industry
4.94%
Market
11.75%
ELAN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ELAN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ELAN vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
ELAN$22.05$21.60-2.04%Strong Buy
VTRS$10.35$12.50+20.77%Buy
RDY$14.58$16.90+15.91%Strong Buy
RGC$15.90N/AN/A
NBIX$144.00$163.36+13.44%Strong Buy
View Top Pharmaceutical Stocks

Elanco Animal Health Stock Forecast FAQ

Is Elanco Animal Health Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NYSE: ELAN) stock is to Strong Buy ELAN stock.

Out of 5 analysts, 3 (60%) are recommending ELAN as a Strong Buy, 1 (20%) are recommending ELAN as a Buy, 1 (20%) are recommending ELAN as a Hold, 0 (0%) are recommending ELAN as a Sell, and 0 (0%) are recommending ELAN as a Strong Sell.

If you're new to stock investing, here's how to buy Elanco Animal Health stock.

What is ELAN's earnings growth forecast for 2025-2027?

(NYSE: ELAN) Elanco Animal Health's forecast annual earnings growth rate of 8.39% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 23.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.09%.

Elanco Animal Health's earnings in 2025 is $434,000,000.On average, 8 Wall Street analysts forecast ELAN's earnings for 2025 to be $442,810,053, with the lowest ELAN earnings forecast at $427,259,784, and the highest ELAN earnings forecast at $452,100,469. On average, 8 Wall Street analysts forecast ELAN's earnings for 2026 to be $495,571,668, with the lowest ELAN earnings forecast at $476,941,154, and the highest ELAN earnings forecast at $521,654,387.

In 2027, ELAN is forecast to generate $559,412,228 in earnings, with the lowest earnings forecast at $496,813,702 and the highest earnings forecast at $596,176,442.

What is ELAN's revenue growth forecast for 2025-2027?

(NYSE: ELAN) Elanco Animal Health's forecast annual revenue growth rate of 3.95% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.75%.

Elanco Animal Health's revenue in 2025 is $4,484,000,000.On average, 6 Wall Street analysts forecast ELAN's revenue for 2025 to be $2,285,523,869,388, with the lowest ELAN revenue forecast at $2,273,916,314,054, and the highest ELAN revenue forecast at $2,294,459,560,632. On average, 6 Wall Street analysts forecast ELAN's revenue for 2026 to be $2,400,631,132,818, with the lowest ELAN revenue forecast at $2,361,512,021,922, and the highest ELAN revenue forecast at $2,434,297,713,334.

In 2027, ELAN is forecast to generate $2,499,095,137,231 in revenue, with the lowest revenue forecast at $2,442,241,764,429 and the highest revenue forecast at $2,572,710,010,711.

What is ELAN's forecast return on assets (ROA) for 2025-2028?

(NYSE: ELAN) forecast ROA is 4.81%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 14.19%.

What is ELAN's Price Target?

According to 5 Wall Street analysts that have issued a 1 year ELAN price target, the average ELAN price target is $21.60, with the highest ELAN stock price forecast at $25.00 and the lowest ELAN stock price forecast at $18.00.

On average, Wall Street analysts predict that Elanco Animal Health's share price could fall to $21.60 by Oct 20, 2026. The average Elanco Animal Health stock price prediction forecasts a potential downside of 2.04% from the current ELAN share price of $22.05.

What is ELAN's Earnings Per Share (EPS) forecast for 2025-2027?

(NYSE: ELAN) Elanco Animal Health's current Earnings Per Share (EPS) is $0.88. On average, analysts forecast that ELAN's EPS will be $0.89 for 2025, with the lowest EPS forecast at $0.86, and the highest EPS forecast at $0.91. On average, analysts forecast that ELAN's EPS will be $1.00 for 2026, with the lowest EPS forecast at $0.96, and the highest EPS forecast at $1.05. In 2027, ELAN's EPS is forecast to hit $1.13 (min: $1.00, max: $1.20).

What is ELAN's forecast return on equity (ROE) for 2025-2028?

(NYSE: ELAN) forecast ROE is 9.75%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.